Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium voltage-gated channel subfamily E regulatory subunit 3 (KCNE3) is a type I membrane protein that functions as a regulatory (beta) subunit for several voltage-gated potassium (Kv) channels, most notably KCNQ1 (Kv7.1)[1][2][5][6]. KCNE3 alters the gating kinetics, trafficking, and current properties of its partner channels, converting the otherwise voltage-dependent KCNQ1 channel into a constitutively open (voltage-independent) potassium (K+) channel, critical for potassium ion recycling and transepithelial chloride secretion in various epithelial tissues, including the intestines and airways[1][2][5]. KCNE3 is expressed in several tissues and can modulate additional Kv channels such as KCNQ4, hERG, Kv2.1, and Kv3.x subfamilies. Genetic variants in KCNE3 are implicated in cardiac arrhythmias, cystic fibrosis severity modulation, and periodic paralysis[4][5][6]. KCNE3 does not form ion channels on its own but exerts profound effects on potassium channel activity through subunit assembly and direct physical interactions with voltage sensor domains of the channel alpha subunits.
Modulation of voltage-gated potassium channel gating kinetics - Stabilization of the activated state of KCNQ1 and related channels - Conversion of KCNQ1 from voltage-dependent to constitutively open state[5][3][1]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily E regulatory subunit 3 (KCNE3).